May 6, 2019
U.S. health authorities will allow a type of breast implant linked to a rare form of cancer to stay on the market, saying its risks do not warrant a national ban. But the Food and Drug Administration said Thursday it …
March 29, 2019
Government medical advisers said this week it’s too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug …
March 22, 2019
Medicines proven to treat opioid addiction remain vastly underused in the U.S., the nation’s top medical advisers said Wednesday. Only a fraction of the estimated 2 million people addicted to opioids are getting the medications, according to a report by …
March 1, 2019
Channeling the ire of constituents and drawing from personal experience, senators chastised drug company executives Tuesday over the high cost of prescription medications, while the CEOs warned that government price controls could stifle breakthroughs on diseases like Alzheimer’s. The Senate …
February 12, 2019
U.S. health officials are telling doctors to be on the lookout for a rare cancer linked to breast implants after receiving more reports of the disease. The Food and Drug Administration sent a letter to family doctors, nurses and other …
November 29, 2018
U.S. health officials said this week they plan to overhaul the nation’s decades-old system for approving most medical devices, which has long been criticized by experts for failing to catch problems with risky implants and medical instruments. The Food and …
July 23, 2018
The maker of a permanent contraceptive implant subject to thousands of injury reports and repeated safety restrictions by regulators said Friday that it will stop selling the device in the U.S., the only country where it remains available. Bayer said …
April 20, 2018
U.S. health officials on Tuesday proposed steps to improve the government’s system for overseeing medical devices, which has been criticized for years for failing to catch problems with risky implants and medical instruments. The plan from the Food and Drug …
February 18, 2016
Recovering from a medical procedure is always a challenge, but getting hit with unexpected insurance fees can add financial hardship to the process. As health insurance plans become increasingly complicated, more patients are facing unexpected fees when they step outside …
March 6, 2015
Federal health officials say that the manufacturer of a medical instrument at the center of a recent “superbug” outbreak in Los Angeles did not receive federal clearance to sell the device. The Food and Drug Administration has confirmed that Olympus …